Clinical Trial: A Study to Evaluate ENERGI-F705 Tablets in Healthy Volunteers

U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07650383) titled 'A Study to Evaluate ENERGI-F705 Tablets in Healthy Volunteers' on May 28.

Brief Summary: To evaluate the safety, the tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) of ENERGI-F705 Tablets in healthy subjects.

Study Start Date: Feb. 24, 2025

Study Type: INTERVENTIONAL

Condition: Health Adult Subjects

Intervention: DRUG: ENERGI-F705 Tablets 60 mg

ENERGI-F705 tablets administered orally under fasting conditions.

DRUG: ENERGI-F705 Tablets 120 mg

ENERGI-F705 tablets administered orally under fasting conditions.

DRUG: Vehicle Control

Matched vehicle control tablets administered orally under fasting conditions.

Re...